Abstract
The treatment of asthma is undergoing significant change with an emphasis on anti-inflammatory therapy. While glucocorticoids are the most potent anti-inflammatory agent, certain patients fail to respond. These patients may be candidates for alternative anti-inflammatory therapy, such as troleandomycin, methotrexate, gold, hydroxychloroquine, or dapsone. In addition, the application of immunomodulator therapy, such as intravenous gamma globulin or cyclosporine, may be useful.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Adrenergic beta-Agonists / therapeutic use
-
Anti-Inflammatory Agents* / administration & dosage
-
Anti-Inflammatory Agents* / classification
-
Anti-Inflammatory Agents* / therapeutic use
-
Asthma / classification
-
Asthma / drug therapy*
-
Asthma / psychology
-
Auranofin / administration & dosage
-
Auranofin / therapeutic use
-
Bronchodilator Agents / administration & dosage
-
Bronchodilator Agents / therapeutic use
-
Cromolyn Sodium / therapeutic use
-
Drug Therapy, Combination
-
Glucocorticoids / administration & dosage
-
Glucocorticoids / chemistry
-
Glucocorticoids / therapeutic use
-
Humans
-
Hydroxychloroquine / pharmacology
-
Hydroxychloroquine / therapeutic use
-
Immunoglobulins, Intravenous / therapeutic use
-
Methotrexate / administration & dosage
-
Methotrexate / adverse effects
-
Methotrexate / therapeutic use
-
Quality of Life
-
Severity of Illness Index
-
Steroids
-
Theophylline / therapeutic use
-
Troleandomycin / administration & dosage
-
Troleandomycin / adverse effects
-
Troleandomycin / therapeutic use
Substances
-
Adrenergic beta-Agonists
-
Anti-Inflammatory Agents
-
Bronchodilator Agents
-
Glucocorticoids
-
Immunoglobulins, Intravenous
-
Steroids
-
Auranofin
-
Hydroxychloroquine
-
Theophylline
-
Troleandomycin
-
Cromolyn Sodium
-
Methotrexate